Improving the Knowledge of X-linked Hypophosphatemia among Clinicians in the Arabian Gulf and African Countries

Abstract

Rare bone disorders comprise ∼5% of all rare disorders.[1] These diverse and heterogeneous disorders are often progressive and associated with impaired mobility, chronic pain, and poor quality of life. Thus, patients often require lifelong multidisciplinary care, including medical therapies, surgeries, and the provision of aids for activities of daily living. X-linked hypophosphatemia (XLH) is one such rare bone condition. In the current issue of JDEP, Beshyah et al[2] undertook an online survey of clinicians in the Middle East and African countries to determine their knowledge of rare metabolic bone disorders and, more specifically, about XLH. While more than 80% of respondents were aware of XLH, the survey identified significant gaps in the clinicians' knowledge of symptoms of the condition and its management during the life course. The findings of this survey are broadly similar to those reported by Deeb et al.[3] They undertook an online survey to determine the awareness, knowledge, and management of XLH among members of the Arab Society for Pediatric Endocrinology and Diabetes.